Kurome Therapeutics to develop therapies targeting cancer’s ability to evade treatment
Kurome enters into licensing agreements and a cooperative research and development agreement with Cincinnati Children's Hospital Medical Center and the ...
Kurome enters into licensing agreements and a cooperative research and development agreement with Cincinnati Children's Hospital Medical Center and the ...
Credit: Sherine Abdelmawla WEST LAFAYETTE, Ind. - A new round of support will help a Purdue University-affiliated startup further develop ...
Credit: University of Colorado Cancer Center An important goal of early-phase clinical trials is to discover a drug's possible side ...
Credit: Michael Wong EDMONTON, Alberta, April 28, 2020 -- Entos Pharmaceuticals (Entos), a healthcare biotechnology company that develops next generation ...
Team of Toronto researchers launches clinical trial to find out if existing HIV medication could prevent COVID-19 infectionCredit: MAP Centre ...
Credit: BIOCAD The first Russian original PD-1 inhibitor Forteca® (INN: prolgolimab) was granted approval for market authorization by the Russian ...
Credit: Image reproduced with permission from RDD Online / Virginia Commonwealth University. New research has revealed new insights into common ...
New drug delivery method could reduce side effects from rheumatoid arthritis drugsCredit: Victoria Wickenheisser Bethesda, MD - Although today's rheumatoid ...
New approach targets problematic molecular pathway to prevent preterm labor and birthCredit: Scott Barnett, University of Nevada, Reno School of ...
Results of a study on lixisenatide in the retina and the optic nerve head in a mouse model of type ...
Credit: University of Saskatchewan The University of Saskatchewan's VIDO-InterVac (Vaccine and Infectious Disease Organization-International Vaccine Centre) has been awarded $23 ...
Fighting degenerative diseasesCredit: UNIVERSITY OF BARCELONA - CIBERER The Sanfilippo syndrome type C is a severe neurodegenerative disease which appearws ...
The work centers around ReFRAME, a vast collection of drugs developed for other diseases that are already known to be ...
Credit: University of Colorado Cancer Center Tejas Patil, MD, is a medical oncologist. Lisa Ferrigno, MD, MPH, FACS, is a ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.